Skip to main content
SMFM 2026 Pregnancy Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared outside of the session
Faculty have requested this content not be shared outside of the session
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording available 2/16-5/2
Recording available 2/16-5/2
AIUM Credit
AIUM Credit
Foundation Awardee
Foundation Awardee
Poster Icons
Abstract Award
Abstract Award
Foundation Awardee
Foundation Awardee

Poster Session 3

Category: Clinical Obstetrics

Poster Session 3

(750) Perinatal Patient Preferences Related to Medications for Opioid Use Disorder: A Discrete Choice Experiment

Thursday, February 12, 2026
10:30 AM - 12:00 PM  
Objective:
Medications for opioid use disorder (MOUD) reduce mortality and morbidity risk for perinatal individuals with opioid use disorder (OUD), yet little is known about their preferences for treatment options. Our objective was to evaluate factors that perinatal individuals with OUD prioritize when considering MOUD options.

Study Design:
We recruited perinatal individuals ages ≥18 with OUD receiving MOUD (buprenorphine, methadone, naltrexone) to participate in a discrete choice experiment (DCE). A power analysis suggested 40 individuals would be needed to detect statistical differences. MOUD attributes were selected through literature review, expert input, and iterative feedback from a panel of people with lived experience. The final DCE included six attributes: treatment effectiveness, risk of neonatal opioid withdrawal syndrome (NOWS), administration (oral vs injection), ease of access (travel time, virtual appointments), frequency of required visits, and pain management support. We collected demographics and participants completed 13 choice sets of two hypothetical treatments with varying characteristics via a web-based application. We applied a mixed logit model to estimate utility scores, with positive and negative values indicating preferences toward and against, respectively, the attributes.

Results:
From March to July 2025, we recruited 26 participants from our multi-disciplinary specialty perinatal addiction clinic. Most identified as White (84%), had public insurance (72%), and were pregnant (56%) (Table 1). Utility estimates indicated that participants had strong preferences for MOUD that offered lower risk of NOWS (β = +0.40; p< 0.01) and were easily accessible (β = +0.32, p = 0.02) (Figure 1). Conversely, participants expressed a preference against required daily visits for MOUD (β = –0.22; p=0.02).

Conclusion:
Perinatal individuals with OUD prioritized reduced NOWS risk and accessible treatment, whereas daily clinical visits, such as those required for methadone, were viewed negatively. Incorporating preferences into clinical decision-making may improve treatment engagement and outcomes.